The Journal of infectious diseases
Autoantibodies against type I interferons are a prominent feature in SARS-CoV-2 fatal disease and hospitalization.
Rebeca Linhares Abreu Netto, Catherine Chen, Victor Irungu Mwangi, Carlos Eduardo Padron de Morais, Mariana Simão Xavier, Luiz Gustavo Gardinassi, Emily Marie Eriksson, Nicholas Kiernan-Walker, Eamon Conway, Ivo Mueller, Marcus Vinícius Guimarães Lacerda, Wuelton Marcelo Monteiro, Fernando Fonseca Almeida-Val, Gisely Cardoso de Melo
Published: 202510.1093/infdis/jiaf514
Abstract
BACKGROUND: Autoantibodies have been implicated as key players in COVID-19 pathogenesis, with evidence of impacting disease severity and poor outcomes. METHODS: We analyzed autoantibody profiles in 435 PCR-confirmed COVID-19 patients in Manaus, Brazi…
Preview only. Read the full abstract at the source